AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Predictive Value of Lung Ultrasound for Respiratory Decompensation in Late Preterm Neonates

Recruitingn/aAges 34 Weeks - 36 WeeksAllHackensack Meridian Health
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Respiratory morbidity presents a significant clinical challenge in the neonatal period, and an individual patient's clinical course is often difficult to predict. This is especially true for late-preterm infants, who share some of the same risks of premature babies in terms or respiratory morbidity, but whose births may not always be attended by a neonatologist, or who may be born at hospitals with lower level Neonatal Intensive Care Units (NICUs) and require transfer if they decompensate. With this study, the aim is to 1) determine the efficacy of early point of care lung ultrasound (LUS) to predict respiratory decompensation in the first 48 hours of life in late preterm infants and 2) to compare the performance of three lung ultrasound scoring systems, 3 type-of-lung, high risk pattern and total LUS scoring systems.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Inborn infants born between 34w0d and 36w6d gestational age * In RA or 1 Litre per minute 1LPM NC (room air (RA) or nasal cannula (NC)) * Admitted to NICU or Well Baby Nursery (WBN) Exclusion Criteria: * Patients born \<34 weeks or \>36w6d * Major genetic anomaly or syndromic condition * Cardiac or pulmonary structural defects * Cord pH \<7.0 or 5 minute APGAR 5 or less * Suspected fetal hemorrhage or other source of significant anemia at birth
๐Ÿ’Š

What it tests

  • Point of care lung ultrasound
๐Ÿ“

Where

1 site
Hackensack Univeristy Medical Center
Hackensack, United States
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy